Eli Lilly’s “triple g” drug helped patients lose about 28.7% of their body weight while also reducing pain associated with ...

In addition, the obesity drug also improved knee pain in participants, Eli Lilly noted. ・Seven additional Phase 3 trials for ...

This new knee treatment, led by researcher Kaitlin Carrato and her team, was shared at a major medical meeting called the ...

A novel triple receptor agonist conferred weight loss of up to 28.7% at 68 weeks and reductions in pain for adults with ...

The event also highlights the importance of non-opioid therapies for managing both acute and chronic pain. Pacira BioSciences ...

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Knee Osteoarthritis Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering ...

The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug.

ORANGE, Calif. (KABC) -- The cartilage around your knee allows it to glide smoothly as you bend and straighten, but once it's torn it can cause excruciating pain. Local doctors are now investigating a ...

A mainstay diabetes medication reduced pain and stiffness and improved function in overweight people with knee osteoarthritis, a new study has found. Effective pain reduction and improved mobility may ...

A new study has found the non-invasive application of in-ear electrical stimulation to the vagus nerve to be safe and effective in reducing osteoarthritis-related knee pain. It opens the door to ...

New treatments are offering hope. One is called pain reprocessing therapy. In this method, patients work with therapists to understand their pain and change how they react to it. The brain learns to ...

The inexpensive diabetes pill metformin significantly reduced pain from knee osteoarthritis in a small trial of people who are overweight or have obesity. Results from a small trial suggest that the ...